MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 220 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,092,064 | +5.3% | 62,995 | 0.0% | 1.99% | -10.6% |
| Q3 2022 | $1,986,000 | -10.6% | 62,995 | -13.7% | 2.23% | -2.9% |
| Q2 2022 | $2,221,000 | +5.6% | 72,995 | -9.9% | 2.29% | +18.1% |
| Q1 2022 | $2,103,000 | -17.9% | 80,995 | -35.5% | 1.94% | -9.3% |
| Q4 2021 | $2,561,000 | +3.9% | 125,554 | -2.0% | 2.14% | 0.0% |
| Q3 2021 | $2,464,000 | -13.3% | 128,088 | 0.0% | 2.14% | -5.4% |
| Q2 2021 | $2,841,000 | -6.4% | 128,088 | +10.8% | 2.26% | -14.2% |
| Q1 2021 | $3,034,000 | +40.5% | 115,571 | 0.0% | 2.64% | +16.1% |
| Q4 2020 | $2,160,000 | +68.4% | 115,571 | +52.9% | 2.27% | +40.9% |
| Q3 2020 | $1,283,000 | – | 75,571 | – | 1.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |